ARAY Accuray Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARAY

Price (delayed)

$0.3571

Market cap

$42.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.37

Enterprise value

$180.44M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: 43
Relative Profitability: Rel. Profitability: 11

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation ...

Highlights
Accuray's debt has decreased by 15% YoY but it has increased by 4.7% QoQ
The quick ratio has declined by 32% year-on-year and by 3.6% since the previous quarter
The net income has declined by 29% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.accuray.com
Peers: SYK

Key stats

What are the main financial stats of ARAY

ARAY stock price

How has the Accuray stock price performed over time
Intraday
-3.38%
1 week
-14.98%
1 month
-22.39%
1 year
-77.54%
YTD
-56.69%
QTD
-7.99%

Financial performance

How have Accuray's revenue and profit performed over time
Revenue
$428.57M
Gross profit
$114.89M
Operating income
-$27.73M
Net income
-$46.13M
Gross margin
26.8%
Net margin
-10.8%
The company's operating margin has shrunk by 63% QoQ
The company's operating income has shrunk by 58% QoQ
Accuray's net margin has decreased by 32% QoQ
The net income has declined by 29% since the previous quarter

Price vs fundamentals

How does ARAY's price correlate with its fundamentals

Growth

What is Accuray's growth rate over time

Valuation

What is Accuray stock price valuation
ARAY P/E details
P/E
N/A
P/B
1.02
P/S
0.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.42
The EPS has contracted by 28% from the previous quarter
The price to book (P/B) is 77% lower than the 5-year quarterly average of 4.6 and 45% lower than the last 4 quarters average of 1.9
ARAY's equity is down by 22% QoQ and by 16% YoY
The price to sales (P/S) is 78% lower than the 5-year quarterly average of 0.5 and 63% lower than the last 4 quarters average of 0.3
Accuray's revenue has decreased by 8% YoY

Efficiency

How efficient is Accuray business performance
The ROIC has shrunk by 52% QoQ
The ROS has plunged by 50% from the previous quarter
Accuray's ROE has decreased by 34% from the previous quarter
The company's return on assets fell by 31% QoQ

Dividends

What is ARAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARAY.

Financial health

How did Accuray financials performed over time
The company's total assets is 10% higher than its total liabilities
The quick ratio has declined by 32% year-on-year and by 3.6% since the previous quarter
Accuray's current ratio has decreased by 13% YoY and by 3.4% QoQ
The company's debt to equity rose by 34% QoQ
ARAY's equity is down by 22% QoQ and by 16% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.